ANTHROMOLECULE Trademark

Trademark Overview


On Tuesday, April 4, 2023, a trademark application was filed for ANTHROMOLECULE with the United States Patent and Trademark Office. The USPTO has given the ANTHROMOLECULE trademark a serial number of 97871746. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, June 17, 2024. This trademark is owned by Montai Health, Inc.. The ANTHROMOLECULE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Nutritional supplements; medical foods, namely, infant, pediatric and adult formulas being dietetic beverages for nutrition purposes; pharmaceutical and therapeutic products, namely, pharmaceutical preparations for the treatment of immunological or metabolic diseases, infectious disease, nutritional deficiencies, oncological disease

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of nutritional supplements, therapeutics, and pharmaceuticals
anthromolecule

General Information


Serial Number97871746
Word MarkANTHROMOLECULE
Filing DateTuesday, April 4, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNutritional supplements; medical foods, namely, infant, pediatric and adult formulas being dietetic beverages for nutrition purposes; pharmaceutical and therapeutic products, namely, pharmaceutical preparations for the treatment of immunological or metabolic diseases, infectious disease, nutritional deficiencies, oncological disease
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of nutritional supplements, therapeutics, and pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 27, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMONTAI THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameMontai Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Friday, April 7, 2023NEW APPLICATION ENTERED
Thursday, April 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 30, 2023ASSIGNED TO EXAMINER
Sunday, December 31, 2023NON-FINAL ACTION WRITTEN
Sunday, December 31, 2023NON-FINAL ACTION E-MAILED
Sunday, December 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 25, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 25, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 8, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 29, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED